TBA Law Blog


Posted by: Julia Wilburn on Apr 30, 2024

The U.S. Drug Enforcement Administration (DEA) has announced that it will move to reclassify marijuana from a Schedule I drug (like heroin and LSD) to a less dangerous Schedule III drug (like ketamine and some anabolic steroids). The Associated Press reports that the proposal would recognize the medical uses of cannabis and acknowledge it has less potential for abuse than some of the most dangerous drugs. However, it would not legalize marijuana outright for recreational use. Schedule III drugs are controlled substances and subject to rules and regulations, and those who traffic them without permission still can face federal criminal prosecution.